Topical Betaxolol for the Prevention of Retinopathy of Prematurity

Clinical trial NCT01660620 · COMPLETED

Trial details

NCT number: NCT01660620
Sponsor: Smith-Kettlewell Eye Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Development of Side Effects From Betaxolol

Start date: 2011-04-01
Primary completion: 2011-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.